Efficacy of Ustekinumab in Crohn's Disease With and Without Concurrent Autoimmune Skin Disease.
Elena FradkovJessica SheehanKelly C CushingPeter D R HigginsPublished in: Inflammatory bowel diseases (2021)
Concurrent autoimmune skin disease in CD is associated with greater ustekinumab effectiveness in controlling intestinal inflammation.